PUT - SPRINTER OPEN END - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 13:55:04 2024-06-28 EDT | ||
| 14.76 EUR | -1.53% |
|
| Current month | -2.06% | ||
| 1 month | -6.11% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 14.76 | -1.53% |
| 24-06-27 | 14.99 | -3.48% |
| 24-06-26 | 15.53 | +1.24% |
| 24-06-25 | 15.34 | +1.99% |
| 24-06-24 | 15.04 | -2.21% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 01:55 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8Q2V |
| ISIN | DE000VQ8Q2V2 |
| Date issued | 2021-06-17 |
| Strike | 385.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.13 € |
|---|---|
| Lowest since issue | 0.32 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8
USD
Average target price
283.2
USD
Spread / Average Target
+22.14%
- Stock Market
- Certificates
- Certificat
